Joseph Nissenfeld
Psychiatry · Monsey, NYNPI 1497956668
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Johnson & Johnson at 26.4% of the total.
Across 114 payments — averaging $25.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$756
- AbbVie$571
- Alkermes, Inc.$336
- Indivior Inc.$255
- Otsuka America Pharmaceutical, Inc.$213
- Teva Pharmaceuticals USA, Inc.$127
- plus $606 from 11 others
What the payments were for
- Food & beverage$2,865100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 28 | $756 |
| AbbVie | 25 | $571 |
| Alkermes, Inc. | 13 | $336 |
| Indivior Inc. | 11 | $255 |
| Otsuka America Pharmaceutical, Inc. | 9 | $213 |
| Teva Pharmaceuticals USA, Inc. | 5 | $127 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $105 |
| Neurocrine Biosciences, Inc. | 3 | $99 |
| Axsome Therapeutics, Inc. | 3 | $88 |
| E.r. Squibb & Sons, L.L.C. | 3 | $78 |
| Almatica Pharma LLC | 2 | $65 |
| Supernus Pharmaceuticals, Inc. | 2 | $40 |
| Luye Pharma (USA) Ltd. | 1 | $31 |
| Sunovion Pharmaceuticals Inc. | 1 | $28 |
| Biogen | 1 | $26 |
| Bausch Health US, LLC | 1 | $24 |
| Lundbeck LLC | 1 | $22 |
How this compares
$2,865 in reported general payments places this provider in the 85th percentile of 3,713 psychiatry providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProzacFluoxetine Hcl | 12 | $17,959 |
| Lamotrigine | 17 | $265 |
| Buspirone Hcl | 13 | $215 |
| Olanzapine | 11 | $188 |
| Lithium Carbonate | 28 | $177 |
| Prazosin Hcl | 12 | $163 |
| Trazodone Hcl | 11 | $132 |
| Haloperidol Decanoate | 11 | $123 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Monsey
- Richard PriceMonsey$1.7M
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Adam AshtonAmherst$1.6M
- Christoph CorrellGlen Oaks$1.5M
- Manish ZinzuvadiaNew York$1.3M
- George KruseBronx$1.2M
- Jianping ChenNew York$1.2M
- Horacio CapoteAmherst$1.1M
- Yadagiri ChepuruYonkers$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.